Citigroup cuts Krystal Biotech target price to $412 from $416
KRYS•Citigroup cut its target price for Krystal Biotech to $412 from $416.
Related News
Australia's central bank lifts rates to 18-year high, split vote points to pause ahead
TLT•
Primis Financial Corp: KBW cuts target price to $17 from $18
FRST•
Lonza agrees to buy five US CDMO sites from Merck
MRK•
HII, Thales demonstrate autonomous mine countermeasure capability
HII•
Krystal Biotech: TD Cowen cuts target price to $380 from $403
KRYS•